13
Jun
GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare
The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescript...
Posts by info@weitaibiotech.com
13
Jun
2026 Global Medical Aesthetic Skincare Trends: Data and Insights for OEM Brands
Trend 1: High-Fidelity Aesthetics67% of aesthetic consumers prefer natural-looking results. PDRN/PN ...
13
Jun
OEM vs. ODM vs. Private Label: Which Skincare Manufacturing Model Is Right for Your Brand?
OEM (Original Equipment Manufacturing)The brand owns the formula IP. Manufacturer produces to exact ...
13
Jun
How to Start a Private Label Skincare Brand: Complete Step-by-Step OEM Guide
Step 1: Market Research and Brand PositioningTarget market: Domestic vs. international; B2C vs. B2B ...
13
Jun
Anti-Aging Sunscreen: The Science of Photoprotection for OEM Skincare Brands
Photoprotection: The Most Important Anti-Aging InterventionDaily sunscreen use reduces visible aging...
13
Jun
Exosomes in Skincare: The Frontier of Regenerative Anti-Aging for OEM Brands
What Are Exosomes?Exosomes are extracellular vesicles (30-150nm) secreted by cells that carry bioact...
13
Jun
Microneedle Delivery Technology: OEM Opportunities in Transdermal Skincare
How Microneedle Technology WorksThe stratum corneum blocks molecules >500 Daltons (collagen: ~300...
13
Jun
Peptide Complexes in Skincare: Key Types, Clinical Evidence, and OEM Formulation
Peptides: Signaling Molecules for Anti-AgingPeptides are short amino acid chains (2-50 residues) tha...
13
Jun
Multi-Weight Hyaluronic Acid: The Science of Superior Hydration for OEM Skincare
Understanding Hyaluronic Acid by Molecular WeightHA is a glycosaminoglycan that holds 1,000x its wei...
13
Jun
PLLA Biostimulators: Complete Guide for OEM Skincare and Injectable Brands
What Is PLLA?Poly-L-Lactic Acid (PLLA) is the gold standard biostimulator in medical aesthetics. Unl...
